Brooks O'Neil
Stock Analyst at Lake Street
(0.75)
# 4,043
Out of 5,163 analysts
34
Total ratings
32.35%
Success rate
-19.03%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $4.38 | +128.31% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.98 | +101.01% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $21.59 | -44.42% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.40 | +81.82% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.16 | +532.91% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $108.06 | +1.80% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $10.39 | +188.74% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $5.19 | +400.96% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $34.10 | +61.29% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $12.28 | +46.58% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.40 | +138.10% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.64 | +89.39% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $23.51 | +10.59% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.22 | +4,801.96% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $21.52 | +492.61% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $4.38
Upside: +128.31%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.98
Upside: +101.01%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $21.59
Upside: -44.42%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.40
Upside: +81.82%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.16
Upside: +532.91%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $108.06
Upside: +1.80%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $10.39
Upside: +188.74%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $5.19
Upside: +400.96%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $34.10
Upside: +61.29%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.28
Upside: +46.58%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.40
Upside: +138.10%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.64
Upside: +89.39%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $23.51
Upside: +10.59%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.22
Upside: +4,801.96%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $21.52
Upside: +492.61%